Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells
Open Access
- 7 November 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (51) , 84645-84657
Abstract
Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cellsKeywords
This publication has 52 references indexed in Scilit:
- Multiplexed Quantum Dot Labeling of Activated c-Met Signaling in Castration-Resistant Human Prostate CancerPLOS ONE, 2011
- Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort studyBreast Cancer Research, 2011
- Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapseBreast Cancer Research and Treatment, 2011
- EPLIN downregulation promotes epithelial–mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasisOncogene, 2011
- Identification of Methylated Genes Associated with Aggressive Bladder CancerPLOS ONE, 2010
- Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cellsMolecular Cancer, 2010
- Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cellsMolecular and Cellular Endocrinology, 2008
- Plexin A3 and plexin A4 convey semaphorin signals during facial nerve developmentDevelopmental Biology, 2008
- A Proteomics Analysis of Cell Signaling Alterations in Colorectal CancerMolecular & Cellular Proteomics, 2007
- Differentiation potential of urothelium from patients with benign bladder dysfunctionBJU International, 2007